This clinical trial is focused on studying a condition known as chronic rhinosinusitis with nasal polyps (CRSwNP), which affects the respiratory tract. People with this condition often experience ongoing nasal congestion, blockage, or obstruction, and may have a reduced sense of smell or nasal discharge. The study aims to evaluate the effects of a new treatment called lunsekimig, which is given as an injection under the skin, compared to a placebo. The goal is to see how well lunsekimig can reduce the size of nasal polyps and improve symptoms in adults who have not found relief with other treatments.

Participants in the study will receive either lunsekimig or a placebo over a period of time. The study will monitor changes in the size of nasal polyps using a special camera that looks inside the nose, as well as changes in symptoms reported by the participants themselves. These symptoms include nasal congestion, nasal discharge, and loss of smell. The study will also look at how the treatment affects the overall health of the sinuses using imaging techniques like CT scans, which create detailed pictures of the inside of the body.

Throughout the study, researchers will keep track of any side effects or adverse reactions to the treatment. They will also measure the levels of lunsekimig in the blood and check for any immune responses to the drug. The study is designed to provide important information about the safety and effectiveness of lunsekimig for treating CRSwNP, with the hope of offering a new option for people who struggle with this condition.